YARDLEY, Pa.--(BUSINESS WIRE)--Feb. 16, 2005--Verispan has introduced a new enhancement to its Vector One(TM): Payer product line, which provides projected market share for individual drugs at the payer level. This latest enhancement allows clients to calculate the average patient cost of a drug during a defined time period. This calculation can be performed by class or product at the national and individual plan level.
